Objectives Arnica montana is a widely used therapeutic plant used traditionally to treat various ailments. The objective of this study was to evaluate the botany, phytochemistry and ethnopharmacology along with special emphasis given on pharmacological activity of plant A. montana. Key findings The plant extracts have been reported to possess antibacterial, antitumor, antioxidant, anti-inflammatory, antifungal and immunomodulatory activity. A wide range of chemical compounds including sesquiterpene lactones and their short-chain carbonic acid esters, flavonoids, carotenoids, essential oils, diterpenes, arnidiol, pyrrolizidine alkaloids, coumarins, phenolic acids, lignans and oligosaccharides, etc., are found in different parts of the plant. Summary It has been scrutinized that extensive research has been carried out to explore the therapeutic potential of flowers of the plant. Therefore, investigations should be carried out to explore the therapeutic potential of other parts of the plant for better therapeutic utilization.
Introduction
Asteraceae, also known as the aster, daisy, composite or sunflower family, is one of the largest flowering plant family containing about 1600 genera and more than 23 000 species and 13 subfamilies. [1] [2] [3] Medicinally important compounds for curing various ailments are found in some genera, e.g. species of Arnica, Centaurea granatensis Boiss., Conyza bonariensis and Senecio doronicum, which are reported for the treatment of variety of ailments. [3] 'Asteraceae' name is give after one of the genus of this family, i.e. 'Aster', which is derived from the Greek word 'ἀrsήq' which means star that denotes its inflorescence. Synantherology is the name given to the study of this family. As its petals open in the morning and close in the evening, members of this family are also called 'Daisy', which is derived from English name: daegesege, which means 'day's eye'. [4] The plants of this family grow as annual and perennial herbs and shrubs, vines or trees in forests to high-altitude grasslands.
[5] Characteristic inflorescences (flowers in dense heads with involucrum) and the calyx forming a pappus crowning the nut are found in this family. [6] A. montana (Asteraceae) is a high-altitude perennial plant indigenous to mountain slopes in Europe, northern Asia, Siberia and America also known as fall-kraut, leopard's bane, sneezewort and mountain tobacco [7] and had proved to be an important medicinal plant. [3] Occurrence, botanical description and ethnopharmacology them and spaced 30 cm apart. Plants may be grown indoor by sowing in pots at 13°C for 1 year and then transplanting them outdoor after last frost. These are cut before flowering to keep stems short and after flowering to produce secondary bloom.
The plant possesses numerous medicinal activity. The flowers of the plant show greater medicinal value and are used as antiphlogistic, inotropic, antibiotic, anti-inflammatory, immunomodulatory, antiplatelet, uterotonic, antirheumatic and analgesic in febrile conditions. [11, 59] Both oral administration of flowers in the form of fresh plant mother tincture and local external application in the form of cream, ointment or gel or in the form of wet poultice comprising of a solution that contains one tablespoon of A. montana tincture to a quarter litre of light warm water have been valued for curing osteoarthritis, alopecia and chronic venous insufficiency. [12] According to European pharmacopoeia (1809), A. montana tincture is produced from A. montana flowers with 0.04% sesquiterpene lactones expressed as dihydrohelenalin tiglate. The tincture contains one part of the drug in 10 parts of ethanol (60% (V/V) to 70% (V/V)). According to European Union, herbal preparation(s) containing A. montana are tincture (1 : 10) extracted with ethanol 70% v/v, tincture (1 : 5) extracted with ethanol 60% v/v and liquid extract (1 : 20) extracted with ethanol 50% m/m, mainly of flowers. Tincture is dried by evaporation, and the extract is incorporated in numerous herbal drug products. [12, 13] A. montana has proved its worth as anti-inflammatory agent. A. montana extract (3-30%) when blended with one or more therapeutic or pharmaceutical agents, i.e. camphor, menthol, eucalyptus oil, mint oil, guaifenesin, topical analgesics, non-steroidal anti-inflammatory drugs or either transdermal opioid analgesics in a petroleum base or pluronic lecithin organogel, reduces inflammation. [14] Alam [15] reported that post-traumatic bruising of skin or postsurgery, postlaser treatment effects can be prevented by applying ointment containing A. montana (30-40%) in a petrolatum base to the affected area of the skin. In Videki et al., US patent No. 5043153, compositions are prepared for the treatment of parodonthopathy and in Marissal et al., US patent No. 4684522, a cosmetic formulation possessing anticellulitis and slandering activity comprising of required content of extracts of various plants such as Hedera haelix L., A. montana L. (containing glycols), Aesculus hipocastanus L., Ruscus aculeatus L., extract containing saponins and kola nut extract containing caffeine has been reported. [16] In another study, by Ayache et al., US patent No. 4795638 revealed a cosmetic preparation for reducing or eliminating cellulite or fat build-up containing an oily base, a rubefacient (extracts of capsicum; nicotinic acid salts like triethanolamine nicotinate; nicotinic acid esters like methyl, ethyl, hexyl, phenyl and benzyl nicitinate and alpha tocopherol nicotinate; nicotinyl alcohol and its organic acid esters like nicotinate and nicotinyl tartarate), one oil soluble plant extract of either climbing ivy, A. montana, marigold, rosemary, ginseng, sage, ruscus, Saint Johns wort, ulmaria, algae, a volatile polysiloxane and orthosiphon. [17] Paradise L. in US patent No. 5795573 A has concluded that homoeopathic topical anti-inflammatory preparations containing synergistic combination of extracts from A. montana, Rhus toxicodendron and Aesculus hippocastanum and belladonna can be used to treat muscular cramps, soreness and pain. In many inflammatory diseases in order to relieve pain or mask pain caused by kinins and kallakreins, it is desirable to promote healing and improve circulation to tissues nerves. US patent No. 5162037 to Whitson-Fischman discloses a homoeopathic mixture to treat pathogenic conditions of body containing one herb or herbal extract of A. montana, Rhus Toxicum, pineal gland and a magnetically permeable substance. [18] Arnica in combination with Ruta graveolens, Aconitum napellus, Bellis perennis, Hamamelis virginiana, Hypericum perforatum, Calendula officinalis, Ledum palustre, Bryonia alba is effective for treating inflammation. [19] Recently, Bilia has reported that both the tincture and the dried extract of the plant are physically incompatible and unstable when formulated as semisolid formulations as well as contain very less content of sesquiterpene lactones. Therefore, he introduced a pioneering supercritical carbon dioxide extract, analysed by both HPLC and NMR spectroscopy containing 9.5%(w/w) of sesquiterpenes. It can be a good substitute for the topical semisolid preparations available in the market. [20] Roots of A. montana contain thymol, which is used for flavouring purposes, as antioxidant in foodstuffs and beverages and also as fungicide, preservative and insecticidal agent. [21, 22] Roots of the plant are also used as bacteriostatic, antiphlogistic, choleretic and cholagogic due to presence of polyacetylenic compounds, phenol esters and phenolcarboxylic acids. [23] Alcoholic or isopropanolic extract of A. montana flowers in the form of liquid formulations such as syrups, tinctures and ointments is used for the treatment of cattle, sheep, horses, swine and goats for inflammation of udder, joints, tendons, skin; eczema and to cure wounds of mucous membrane and skin. [23] A. montana in combination with Echinacea angustifolia, Eupatorium perfoliatum and Baptisia tinctoria is used to treat upper respiratory infections. [24] Numerous homoeopathic preparations of the plant are available in the market such as Hyland's Arnicated hair oil, shampoo, Arnica ointment, Arnica tablets and pellets [69, 129, 309, 30CH, 200CH ], Hyland's Arnica spray as the plant possesses various activities. Bioactive constituents such as sesquiterpene lactones, i.e. helenalin an 11a,13-dihydohelenalin, phenolic acids and flavonoids, have been isolated by various chemical and pharmacological analyses of the plant which acts as anti-inflammatory agent, antioxidant, antiphlogistic, immunomodulatory and used to treat various ailments like osteoarthritis. Cosmetic, pharmaceutical and nutraceutical utility of A. montana ethanolic seed extract has been reported in combination with other plant active constituents or either alone. It has also been reported in literature that decoction, infusion or macerated extracts of A. montana flowers, leaves or aerial parts of the plant can be used to treat numerous ailments such as bowels ache, cough, contusion, cuts, haematoma, headache and rheumatism. [3] As recognized in US Pat. No. 4569839, A. montana also has soothing and healing properties for the hair and skin. As taught in US Pat. No. 3832343 by Majoie et al., perhaps the most common topical use for A. montana is in the treatment of haematomas as it prevents coagulation of blood. In US patent No. 4938960 to Ismail, extract of A. montana promotes blood circulation and is therefore used for treatment and protection of the skin on the theory that the A. montana will increase the action of the vitamin E in the composition. [25] Phytochemistry One hundred and fifty therapeutically active substances are present in A. montana plant, i.e. sesquiterpene lactones, i.e. helenalin,11a,13-dihydohelenalin and their short-chain carbonic acid esters (0.3-1% of dry weight in the flower heads, 0.1-0.5% in leaves), flavonoids (0.6-1.7%) by micellar electrokinetic capillary chromatography [26] in the form of flavonoid glycosides, flavonoid glucuronides and flavonoid aglycones; essential oils, composed thoroughly of fatty acids, thymol derivatives, monoterpenes and sesquiterpene. Other constituents of A. montana are carotenoids; diterpenes; arnidiol (a triterpene); pyrrolizidine alkaloids (tussilagine and isotussilagine) [27] ; polyacetylenes; coumarins (umbelliferone and scopoletin); phenolic acids (chlorogenic acid, caffeic acid and cynarin, 1.0-2.2%) [26] ; lignans; dicaffeoyl quinic derivatives (1,3-3,5 and 4,5 dicaffeoyl quinic acids); and oligosaccharides. [22] It contains sesquiterpene lactones being metacryl, isobutyryl, tygloyl, methacryloyl, isovaleryl helenalin derivatives, [28] apigenin, luteolin, hispidulin, quercetin and kaempferol glycosides in high quantities. Phytochemical study of A. montana notifies that the nature and amount of phytochemicals such as caffeic acid derivatives, phenolics and helenalin esters and dihydrohelenalin esters present in the flower heads vary according to climatic conditions (i.e. temperature and rainfall) and altitudinal variations. It has been investigated by many researchers that flowers of the plant are mainly rich in active constituents. [26, 29, 30] The content and nature of sesquiterpene lactones vary with altitude. The flowers collected from high-altitude healthlands contain principally helenalin esters while the flowers from lower altitude meadows contain dihydrohelenalin esters in large amount. In another study, the effect of ecological factors has been investigated on the content of sesquiterpene lactones in 10 German healthlands. Higher content of sesquiterpene lactones (0.59-1.10%) was found in the flower heads collected from the foothills of the Alps. [23] The phytochemistry of different parts of plant is discussed below.
Whole plant (Arnicae planta tota)
Various analytical methods such as gas chromatography with mass selective detection (GC-MSD), spectrophotometric, reverse-phase liquid chromatography (RPLC) and proton nuclear magnetic resonance spectroscopy (1HNMR) have been used for analysing the quantity of lactones present in the plant. [28, [31] [32] [33] Geographical range has significant effect on the ratios of helenalin and dihydrohelenalin esters of A. montana: helenalin esters are mainly present in central European collections, while dihydrohelenalin esters are present principally in Spanish collections. Pulhmann et al. in 1991 has reported that methylation analysis, partial acidic and enzymatic hydrolysis and 13C NMR spectroscopy have been used for the identification of two homogeneous polysaccharides from cell cultures of A. montana, an acidic arabino-3, 6-galactan-protein with mean molecular weight of 100 000 and a neutral fucogalactoxyloglucan with mean molecular weight of 22 500 isolated by DEAE-Sepharose CL-6B and Sephacryl S-400 column chromatography. [23] Arnica montana flowers (Arnicae flos) (Figure 3) have also been isolated. [21, 27, 34] The flowers of Arnica species contain especially different sesquiterpene lactones which have a pseudo-guajonolide structure, which often may occur as ester derivatives such as 2,3-dihydroaromaticin, chamissonoid, mexicanin 1 (Figure 4) . [10] The total amount of sesquiterpene lactones vary with maturity of dry flowers; i.e. the amount increases from 0.5% in buds to 0.9% in withered flowers. Sesquiterpene lactones are reported as good anti-inflammatory and cytotoxic agents. [23] Seeds Dziki in 2009 reported that seeds contain mainly phenolic acids (chlorogenic, caffeic acid, quercetin and kaempferol) ( Figure 5 ) and flavonoids (luteolin and apigenin) (Figure 6 ), respectively, as active principles. [35] Aiello in 2014 reported that the seed yield can be increased with years of cultivation if regularly fertilizers are added. Figure 1 Dicaffeoyl quinic derivatives/ phenolic acids of Arnica montana plant. [23, 34] Roots (Arnicae radix)
Pljevljakusic et al. carried out both quantitative and qualitative analyses using GC-FID and GC-MS and concluded that the main constituents of rhizome and root oils are aromatic compounds, i.e. 2,5-dimethoxyp-cymene (28.9-30.0% and 37.9-40.6%, respectively) ( Figure 7 ), thymol methyl ether (26.1-27.1% and 9.6-10.6%, respectively) ( Figure 8 ), pmethoxyheptanophenone (6.1-8.9% and 7.0-7.5%, respectively) and 2,6-diisopropylanisole (8.9-10.4% and 12.8-14.1%, respectively) ( Figure 9 ) . The essential oil from roots and rhizome also contains camphene, phellandrene, limonene, 5p-mentha-2,4(8)diene, terpineol, carvacrol, methyl ether, p-diisopropyl-benzene, bornyl acetate, thymol silphiperfol-5-ene, 7-epi-silphiperfol-5-ene, silphiperfol-6-ene, modheph-2-ene, isocomene, isobornyl isobutanoate, trans-caryophyllene, 2,5-dimethoxypara-cymene, trans-bergamotene, 2,6 diisopropylanisole, cis-farnesene, germacrene, pinchotene acetate, p-methoxyheptanophenone, isobornyl 2-methyl butanoate, isobornyl [ 27] isovalerate, sesquiphellandrene, dimethyl-ionone, lignans and zierone (Figures 4, 7 and 9). Light microscopy, scanning microscopy and transmission microscopy were used to study the secretory tissues localized as idioblastic secretory cells in the cortical region of the root and rhizome for essential oil synthesis. [37] Petrova reported that the amount of essential oils varies in different parts of A. montana, from 2.70 to 6.91% in rhizomes and 1.77 to 3.76% in roots. Kennedy in 1998 found that ethanolic extract of roots contains a panel of non-reducing oligofructosides in later period of growth and both non-reducing oligofructosides and reducing inulin-type oligofructosides in early growth period. [38] In 2011, Weremczuk-Jezyna et al. separated 56 active principles from the essential oil of which 10-isobutyryloxy-8,9-didehydro-thymol isobutyrate and 10-isobutyryloxy-8,9-didehydro-thymol methyl ether were the main components obtained by hydrodistillation of hairy roots of the plant (Shown in Figure 3 ). He carried out image analysis using LEICA DCML microscope having IM1000 (Imagic Bildverarbeitung AG Software company, Opfikon, Switzerland) software and a digital camera. [39, 58] 
Bioactivity
Arnica montana possesses significant anti-inflammatory, antibacterial, antifungal antioxidant and immunomodulatory activity.
Anti-inflammatory activity
Arnica montana has significant anti-inflammatory potential. Huber et al. in 2011 disclosed that the molecular mechanism of sesquiterpene lactones differs from that of non-steroidal anti-inflammatory drugs, i.e. indomethacin and acetyl salicylic acid. These lactones significantly decrease NFkappaB-mediated inflammation as they pass through the skin easily. [40] Phosphorylation and degeneration of IkappaB, NF-kappaB's inhibitory subunit, stimulates NF-kappaB. NFkappaB activation by T cells, B cells and epithelial cells is inhibited by helenalin which in turn blocks kappaB-driven gene expression. This blockage is precise and is due to alteration of NF-kappaB/IkappaB complex, inhibiting the discharge of IkappaB by helenalin. [41] Arnica 6c has been Sesquiterpene lactones and its derivatives of Arnica montana plant. [28, 37] investigated for its anti-inflammatory potential on carrageenin and rat paw oedema induced by nystatin. Arnica 6c significantly reduced inflammation while in case of histamine-induced oedema, the action of histamine was inhibited and the vascular permeability was increased. [42] Research also investigated that when a solution of A. montana 6cH, dexamethasone or 5% hydroalcoholic solution is injected into male adult Wistar rats, they show marked anti-inflammatory activity. Kawakami et al. in 2011 reported a series of inflammatory-positive cells, which play a major role in inflammatory process, i.e. CD54 (ICAM-1), CD18 (BETA 2 integrin), CD45RA (B lymphocytes), CD3 (T lymphocytes), CD163 (ED2 protein) and MAC 387 (monocytes and macrophages). It was concluded that rats that presented oedema after a long time exhibited minor oedema, less degranulation of mast cells and increase in diameter of lymphatic vessels. [43] In another study, it was concluded that acute non-fibrosed mastitis can be effectively treated with Arnica 30CH when taken orally in combination with Healwell VT-6 (comprising of Calcarea fluorica 200CH, Conium 30CH, Silicea 30CH, Phytolacca 200CH, Belladonna 30CH, Ipecacuanha 30CH and Bryonia 30CH). [42] It has also been reported by Sandra et al., [12] that A. montana when administered with herbs like Rue, Willow bark, St. John's Wort and Comfrey treats by improving musculoskeletal healing in case of deep-rooted complaints like arthritis or mainly in the first 24-48 h of an accident.
Anti-osteoarthritic activity
Widrig et al. in 2007 prepared a topical A. montana gel containing helenalin, 11_,13-dihydrohelenalin and its ester that shows significant antiosteoarthritic activity by blocking the transcription factor NF-aB and NF-AT. It promotes functional capacity of hands and reduces the time period and extent of morning stiffness, intensity of pain and the number of painful joints. [44] Immunomodulatory activity
Polysaccharide fraction of A. montana flowers are reported to show significant immunostimulating properties (increase of phagocytosis by granulocytes). [24] DEAE-Sepharose CL-6B and Sephacryl S-400 column chromatographic techniques were used to isolate two Figure 7 Terpenes of Arnica montana plant. [37] polysaccharides from cell cultures of A. montana, i.e. an acidic arabino-3,6-galactan-protein (mean Mr 100 000), which activates macrophages to release tumour necrosis factor and possess anticomplementary activity and neutral fucogalactoxyloglucan (mean Mr 22 500), which increases phagocytosis. [45] OH O I-But O 10-isobutyryloxy-8,9-didehydro-thymol Thymol methyl ether Figure 8 Thymol derivatives of Arnica montana plant. [37] O Figure 9 Other phytoconstituents of Arnica montana plant. [37] Antimicrobial activity
Arnica montana extracts also exhibit antimicrobial activity against Streptococcus sobrinus 6715 and Strep. Mutans -OMZ 175. Agar diffusion method was used, and zones of inhibition were measured. Slight inhibition was observed of the growing cells (19% for Strep. mutans -OMZ 175 and 15% for Streptococcus sobrinus 6715) and of water-insoluble glucan formation (29%) at these same concentrations. [46] These thymol derivatives present in the roots of A. montana have been reported to have bactericidal and fungicidal property whereas the essential oil extracted from the roots of the plant shows antiphlogistic action. [21] Anti-osteoporotic activity (ossification) US Pat. No. 5478579 by Sawruk taught that A. montana is a significant source of flavonol aglycone glycoside which when combined in specific dose with calcium assists in absorption of calcium through a chelation delivery system. [47] Improves circulation Arnica montana is reported to relieve symptoms of diseases relating to the restricted blood flow to nerve endings and the limbs of patients, and reflex sympathetic dystrophy syndrome, which includes fibromyalgia, toxic neuropathy and diabetic neuropathy. [18] Ureotonic activity
The alcoholic extracts of A. montana flower heads or sesquiterpene lactones isolated from the plant show significant uterotonic and contraction-enhancing activity in rabbits, rats and cats when injected intravenously (0.3 ml of an extract). [21, 48] 
Increase respiration
Sesquiterpene lactones, i.e. 6-O-acetyl-11,13-dihydrohelenalin present in A. montana, are also reported to increases respiration frequency and volume by 35 and 43%, respectively, in rats and rabbits when injected intravenously, 0.25 mg/kg bw. [21] 
Inotropic activity
Helenalin isolated from A. montana show significant biphasic positive inotropic effect on the myocardium of guinea pigs at concentrations of 10 À5 -10 À3 mol. [49] However, concentrations above 10 À3 mol cause an irreversible negative inotropic action leading to a block of muscle contraction. [21] Internal use of A. montana at a dose of five drops, three times a day, improves the mild weakness of heart and angina pectoris. [12] Anxiolytic
It was observed that the tannins and flavonoids present in A. montana extract decrease the exploratory activity and locomotor activity in mice and mice spent more time in light compartment and therefore had anxiolytic effect. The development of immobility during forced swimming test indicated the cessation of affective/motivational behaviour. [50] Antioxidant and protective effect Arnica montana extract shows significant antioxidant potential. DPPH (2,2 0 -diphenyl-1-picrylhydrazyl radical) free radical scavenging method and phosphomolybdate method have been utilized to determine the antioxidant potential of the plant. At concentration of 5 mg/ml, A. montana shows 71.52% DPPH scavenging potential and 63.68% total antioxidant activity (phosphomolybdate method) which is mainly attributed due to the presence of flavonoids and phenolic compounds. [49, 51] Camargo et al. in 2013, evaluated homoeopathic A. montana's effect on Ca2 + and inorganic phosphate-induced mitochondrial oxidative stress or/and lipid peroxidation mediated by Fe2 + citrate by alterations rates of oxygen consumed using mitochondrial suspensions prepared by the livers of Wistar strain male rats. Arnica 30cH showed remarkable reduction in mitochondrial O 2 consumption. Arnica 30cH provides protection against Ca 2+ and inorganic phosphate-induced hepatic mitochondrial membrane permeability, lipid peroxidation mediated by Fe 2+ citrate and reactive oxygen-mediated protein fragmentation. [52] Hepatoprotective activity Phenolic compounds isolated from A. montana are used to revive the bile forming function of liver and improve the release of chelates and bilirubin and the removal of cholesterol. [53] Marchishin et al. in 1983 have reported that Arnica when administered to rats with carbon tetrachloride that induced liver injury increases the synthesis and excretion of bile acids, bilirubin and cholesterol; bile secretion also accelerates the activity of serum enzymes. [53] Insecticidal activity Arnica montana furnished insecticidal monoterpenoids which play significant role against store grain pest Tribolium castaneum. Alcoholic dilutions of extracts of drugs were prepared in various concentrations, increase the percentage mortality when used in concentrations, 1-100 mg/ 2 ml against store grain pest. In this study, methanol was used as control and permethrin as standard. [50] Hypopigmentation activity Skin withers with age and also by different environmental stressors such as solar ultraviolet radiation, which leads to skin damage such as thickening like plaque, deep furrowing, wrinkle formation, erythema, loss of skin tone and also hyperpigmentation as a result of increased melanin formation. AM-2 (helenalin 2-methylbutyrate) or A. montana extract when used to treat cultured mouse melanoma cells boosts the HSP70 gene expression with increase in dose and also activates the transcription factor for hsp genes, i.e. heat shock factor-1. It is concluded that both A. montana extract and AM-2 can give good results if incorporated in hypopigmenting cosmetics. [54] Antihair loss activity Kennedy et al. in 2012 concluded that A. montana (1.6-2.6% by weight of formulation) in combination with aqua ammonia in herbal preparations promote hair follicles, increase hair strength and growth of hair. [55] Similarly, Keeney et al. in 2000 introduced a solution containing aloe vera gel, A. montana flowers, comfrey leaves, jaborandi leaves, elkweed, chamomile flowers, colloidal silver solution, horsetail herbal extract, jojoba, collagen, napca, elastin, saponins and rosemary leaves to be applied topically for boosting growth of hair. [51] Antiplatelet activity Pawlaczyk et al. in 2009 found that hexuronic acids and phenolic glycoconjugates present in A. montana are responsible for the anticoagulant activity of the plant. [56] The activity was calculated tests on human plasma such as prothrombin time and activated partial thromboplastin time test. [49] In 1990, Schroder et al. demonstrated that the sesquiterpene lactones, i.e. helenalin and 11a-13-dihydrohelenalin, are mainly responsible for the antiplatelet activity of the plant using human venous blood for test. Helenalin contains an a-methylene-r-butyrolactone and an R-unsaturated cyclopentenone moiety which reacts with intracellular thiol groups leading to their depletion and inhibiting aggregatory activity and secretory activity in platelets. Both compounds interact with platelet sulfhydryl groups causing inhibition of formation of thromboxane, secretion of 5-hydroxytryptamine and platelet aggregation induced by collagen at 3-300 ukl concentration as a result of decreased phospholipase A2 activity. [11] Analgesic Arnica montana extract is also marked in literature to heal wounds. In mice, acetic acid-induced writhing test was used to measure this activity. 0.6% acetic acid per kg was injected intraperitoneal, and it was concluded that A. montana, reduces writhes maximally at a dose of 100 mg/kg. [49] In another study, it is reported that A. montana alone or in combination with H.perforatum gel heals surgically induced incision on the back of Wistar rats effectively. [57] Anticough Arnica 6CH pills showed significant potential against oesophageal reflux which is a very productive cough, hiatus hernia. Bruises disappeared immediately, and the cough was gone too. [58] Antihaemorrhagic activity Stem tincture of A. montana was found to possess antihaemorrhagic activity in women of age group 20-35 years, which reduced postpartum blood loss, which is the significant cause of perinatal morbidity and worldwide mortality, and which occurs in 4% of vaginal deliveries. [59] Clinical studies Many clinical studies have been carried out on A. montana. Data are given in Table 1 .
Toxicological studies
The oral LD50 of an extract was >5 g/kg in rats and 123 mg/kg in mice. The LD50 using intraperitoneal administration was 31 mg/kg for mice. It has been reported in literature that Arnica preparations does not show any signs of contact dermatitis (when used topically), or any ocular irritation, phototoxicity but shows mutagenic effects due to flavanols present in the plant. The Arnica extract increased the numbers of revertants 2-4 times when determined by utilizing S. Typhimurium TA98 and TA100 in the AMES test. The adverse effects may occur with a frequency of 1 : 100, and it depends on the immune system of individual. [10] Some of the laboratory findings of side effects of Arnica preparations are reported in Table 2 . [63] Randomized placebocontrolled trial [10] Double-blinded; placebo- 
Chronic venous insufficiency
No diuretica
Changes were in the combination treatment, but differences were not statistically significant
Lokken et al. [65] Double-blind, placebocontrolled crossover trial [66] Double-blind placebo- [67] Randomized double-blind [58] Computerized literature searches were performed to retrieve all placebo-controlled studies on the subject. [70] Randomized, prospective, multicentre double-blind [10] Double-blinded placebocontrolled 4 weeks 1 Arnica compress (prepared from the whole plant extract, 0.7%) [72] This open multicentre trial [73] Randomized double-blind, placebo-controlled study [74] Prospective, randomized, double-blind, placebocontrolled pilot trial [76] Open, multicentre trail 6 weeks 1 Arnica gel (20% tincture) 2 placebo
patients
Mild-to-moderate knee osteoarthritis
Not reported
Arnica decreased the pain, stiffness of knee and was effective than placebo [77] Randomized double-blind placebo-controlled study [80] Randomized double-blind clinical study [81] A phase 3 monocentric randomized placebocontrolled study [82] Randomized double-blind, parallel-group study [83] Randomized, double-blind, placebo-controlled trial [85] Randomized, double-blind placebo-controlled trial [40] Single-blind, randomized 30 days [89] Not reported 
Conclusion
In this review, the morphology, distribution, pharmacological data and phytochemistry of the medicinal plant, A. montana, have been studied. The pharmacological and phytochemical studies of the plant have revealed that the plant possess numerous activities. Although from time immemorial, the extracts of the plant have been utilized to treat various ailments but proper investigation of its mechanism of action, pharmacotherapeutics, toxicity profile, standardization and clinical studies, modern dosage forms of various phytoconstituents present in the plant can be prepared. Till date, significant investigations have been carried out on exploring the medicinal potential of the flowers of the plant. So, now there is a need to explore the medicinal potential of other parts of the plant to produce economic and therapeutically better products.
